get a key
steadybase-$ company APVO
account_id none on file
legal_name Aptevo Therapeutics Inc.
ticker APVO
cik 1671584
domain aptevotherapeutics.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 19 executives 11 family 0
why_nownone on file
callsnone on file
filings
This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.

filing / Aug 31, 2026 / receipt

In calculating the size of the increase in the authorized number of shares issuable under the Fifth Amended Plan, our Board considered, among other things, our hiring plans and expected number of employees, our historical and projected share usage under our stock incentive plans, our “burn rate,” our current overhang in shares issuable upon exercise of outstanding awards granted under our stock incentive plans, the e

filing / Aug 31, 2026 / receipt

In calculating the size of the increase in the authorized number of shares issuable under the Fifth Amended Plan, our Board considered, among other things, our hiring plans and expected number of employees, our historic and projected share usage under our stock incentive plans, our “burn rate,” our current overhang in shares issuable upon exercise of outstanding awards granted under our stock incentive plans or as in

filing / Aug 31, 2026 / receipt

Marvin L. White (Officer & Director)

filing / Aug 31, 2026 / receipt

Jeffrey G. Lamothe (Officer & Director)

filing / Aug 31, 2026 / receipt

Daniel J. Abdun-Nabi (Director)

filing / Aug 31, 2026 / receipt

John E. Niederhuber, M.D. (Director)

filing / Aug 31, 2026 / receipt

Zsolt Harsanyi, Ph.D. (Director)

filing / Aug 31, 2026 / receipt

Grady Grant, III (Director)

filing / Aug 31, 2026 / receipt

Barbara Lopez Kunz (Director)

filing / Aug 31, 2026 / receipt

Seattle office lease, including amendment $ 3,484 $ 3,810 Total operating leases $ 3,484 $ 3,810 10 Lease payments: For the Six Months Ended June 30, (in thousands) 2026 2025 For operating leases $ 688 $ 688 As of June 30, 2026 , the long-term and current portion of the lease liabilities was $ 3.3 million and $ 0.9 million, respectively.

filing / Aug 14, 2026 / receipt

Jeffrey G. Lamothe 61 President and Chief Executive Officer of Aptevo

filing / Jul 31, 2026 / receipt

executives
Barbara Lopez Kunz Director nominee - receipt
Daniel J. Abdun-Nabi Director - receipt
Daphne Taylor SVP & Chief Financial Officer linkedin receipt
Dirk Huebner Senior Vice President, Chief Medical Officer - receipt
Grady Grant, III Director - receipt
Jeffrey G. Lamothe President and Chief Executive Officer - receipt
John E. Niederhuber Director - receipt
Marvin L. White Officer & Director - receipt
Mary Janatpour Senior Vice President, Chief Scientific Officer - receipt
SoYoung Kwon Senior Vice President, General Counsel, Business Development and Corporate Affairs - receipt
Zsolt Harsanyi, Ph.D. Director nominee - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$